SCHEMBL2489246

SCHEMBL2489246

[CH2]c1ccc(-c2ccccc2)c(-c2ccccc2)c1N(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
CKS1B P61024 1/20 0.33
SKP1 P63208 1/20 0.33
SKP2 Q13309 1/20 0.33
HTR7 P34969 2/20 0.32
BRD4 O60885 1/20 0.32
BRD2 P25440 1/20 0.32
ESR2 Q92731 1/20 0.32
LMNA P02545 1/20 0.31
HTT P42858 1/20 0.31
PSMB5 P28074 2/20 0.31
CSNK1D P48730 1/20 0.31
MAPK11 Q15759 1/20 0.31
MAPK14 Q16539 1/20 0.31
PTGS1 P23219 1/20 0.31
PTGS2 P35354 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19929762 0.84 MAPT (0.43) MAPTKDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL2488675 0.81 KDM4E (0.38) MAPTKDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL2493494 0.78 ADORA1 (0.40) HTR7
SCHEMBL2491939 0.76 CRHR1 (0.38) MAPTKDM4EMEN1KMT2AHTT
SCHEMBL4870784 0.76 LMNA (0.39) MAPTBRD4BRD2ESR2LMNA
SCHEMBL2490178 0.75 BRD4 (0.38) MAPTMEN1KMT2ABRD4BRD2
SCHEMBL11409328 0.73 MAPT (0.43) MAPTKDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL2489466 0.71 ALOX5AP (0.35) MAPTMEN1KMT2ALMNAHTT
SCHEMBL2492329 0.71 HDAC4 (0.45) MAPTESR2LMNAHTTALOX5
SCHEMBL19929763 0.71 MAPT (0.42) MAPTKDM4EMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2380567-B1 MELANIN PRODUCTION INHIBITOR POLA CHEM IND INC (JP) 2019-01-16 EP disclosed
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH MAPT 3454/4885KDM4E 2772/4885MEN1 1585/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 MAPT 3294/4885KDM4E 3096/4885MEN1 1346/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R MAPT 3128/4885KDM4E 3125/4885MEN1 1200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.